Zynerba Pharmaceuticals Encourages Stockholders to Evaluate Impending Tender Offer by Harmony Biosciences
IntroductionDEVON, Pa., Sept. 29, 2023 - Zynerba Pharmaceuticals Inc. (Nasdaq: ZYNE), a leading innovator in pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders, has release...
Sep 29, 2023
Shares